In this episode of GEN's Touching Base, editors talk about neuroscience research updates, insights into how investors are approaching the changing AI landscape, and business updates on profits and buyouts. The post Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics appeared first on GEN – Genetic Engineering and Biotechnology News.
You may also like
StockWatch: Lilly’s Up-to-$3.8B Deal for AtaiBeckley...
Organ Aging Linked to Breakdown in Immune Cell...
Biotronik Neuro snaps up spinal cord stimulation...
Why Commercial Evidence Is the Next Breakthrough in...
Operating at the speed of science: The new medical...
Why modern clinical trials need a finance-first...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.